| Long name: |
Alpha-synuclein (nitro-Tyr39) Antibody |
| Also known as: |
Alpha-synuclein (nitro-Tyr39) Antibody |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
Alpha-synuclein nitro-Tyr39 |
| Specificity: |
This is a highly specific antibody against Alpha-synuclein nitro-Tyr39 |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
KLH conjugated synthetic nitrylpeptide derived from human Alpha-synuclein around nitrosation site of Tyr39 |
| Tested Applications: |
IF(IHC-P), IHC-P, WB |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity: |
Mouse, Rat, Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
A mutant form of Alpha-synuclein has been found in patients with early onset Parkinsonâ, Abnormal platelet function in Alzheimerâ, Alpha-synuclein is localized to neuronal cell bodies and synapses, Alpha-synuclein was first identified as a component of Alzheimerâ, During megakaryocytic differentiation Alpha-synuclein has been found to be upregulated, are predominantly expressed in the brain and are speculated to be involved in synaptic regulation and neuronal plasticity, including Alpha-synuclein (also designated NACP for non-Beta-Amyloid component) and Beta-synuclein, indicating that coordinate expression of synucleins may be important during hematopoetic cell differentiation, while Beta-synuclein is downregulated, &euro, &euro, &euro, &trade, &trade, &trade, The synuclein family members, s disease, s disease amyloid plaques, s disease has been demonstrated |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
Alpha synuclein, Alpha-synuclein, Alpha-synuclein nitro Tyr39, Alpha-synuclein nitro-Tyr39, MGC105443, MGC110988, MGC127560, MGC64356, NACP, Non A beta component of AD amyloid, Non A4 component of amyloid precursor, Non-A-beta component of alzheimers disease amyloid , PARK 1, PARK 4, PARK1, PARK4, PD 1, PD1, Parkinson disease familial 1, SNCA, Snca synuclein, Synuclein, Synuclein alpha, alpha non A4 component of amyloid precursor, alpha non A4 component of amyloid precursor, alphaSYN, isoform NACP140, nitrated Alpha synuclein, nitrated Alpha-Synuclein, nitrated Alpha-synuclein nitrated-Tyr39, nitrated Alpha-synuclein nitro-Tyr39, precursor of, SYUA_HUMAN |
| Description: |
- or alpha protein sometimes glycoprotein present in blood, The Alpha-synuclein (nitro-Tyr39) Antibody is a &alpha |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
Alpha-synuclein (nitro-Tyr39) |
| Short name: |
Alpha-synuclein (nitro-Tyr39) Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
a-synuclein (nitro-Tyr39) (Antibody to) |
| Alternative technique: |
antibodies |